Literature DB >> 28282647

Suboptimal Prenatal Syphilis Testing Among Commercially Insured Women in the United States, 2013.

Robyn Neblett Fanfair1, Guoyu Tao, Kwame Owusu-Edusei, Thomas L Gift, Kyle T Bernstein.   

Abstract

United States surveillance data demonstrate that congenital syphilis cases are increasing. We performed an analysis of commercially insured pregnant females using MarketSan to determine syphilis screening rates at different prenatal stages; 85% of pregnant women in this population had a syphilis test performed at least once during the prenatal period.

Entities:  

Mesh:

Year:  2017        PMID: 28282647     DOI: 10.1097/OLQ.0000000000000569

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  5 in total

1.  Provider Adherence to Syphilis Testing Recommendations for Women Delivering a Stillbirth.

Authors:  Chirag G Patel; Jill S Huppert; Guoyu Tao
Journal:  Sex Transm Dis       Date:  2017-11       Impact factor: 2.830

2.  A descriptive study of syphilis testing in Manitoba, Canada, 2015-2019.

Authors:  Souradet Shaw; Pierre Plourde; Penny Klassen; Derek Stein
Journal:  Can Commun Dis Rep       Date:  2022-02-24

3.  Sexually transmissible infection testing among pregnant women in the US, 2011-15.

Authors:  Jami S Leichliter; Laura T Haderxhanaj; Thomas L Gift; Patricia J Dittus
Journal:  Sex Health       Date:  2020-02       Impact factor: 2.706

4.  Syphilis testing adherence among women with livebirth deliveries: Indianapolis 2014-2016.

Authors:  Opeyemi C Ojo; Janet N Arno; Guoyu Tao; Chirag G Patel; Brian E Dixon
Journal:  BMC Pregnancy Childbirth       Date:  2021-10-30       Impact factor: 3.105

5.  Using Surveillance Data to Respond to an Outbreak of Congenital Syphilis in Arizona Through Third-Trimester Screening Policies, 2017-2018.

Authors:  Kaitlyn J Sykes; Rebecca A Scranton; Lisa Villarroel; Bree V Anderson; Sara Salek; Jonathan Stall
Journal:  Public Health Rep       Date:  2020-11-19       Impact factor: 2.792

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.